alternatives to glp 1 injections OZEMPIC: Risks, Benefits, and Natural GLP-1 Weight-Loss Drugs Medicine Guide – Tagged "glp1

Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)

Data regarding the cancer risk associated with tirzepatide are limited in the published RCTs

Lessons From GLP-1/Glucagon Co-Agonists in Clinical Development The first GLP-1/glucagon co-agonist to advance to human clinical trials was cotadutide (MEDI0832)

ROC found 21.3 hours of fasting from solid food as the cutoff for increased prevalence of high RGC. 2 AUC of 0.6 for both ROC curves suggests statistical significance, but with weak prediction model

JAMA 330 , 512527 (2023)

Combined SGLT2i and GLP-1RA therapy resulted in a significantly lower risk of all-cause death, non-fatal myocardial infarction, and non-fatal stroke at 12 months than SGLT2i monotherapy (HR, 1.77